Improving HPV vaccination rates through standing orders
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
This study tests if allowing healthcare team members to give HPV vaccines without needing a doctor's order can help more kids aged 11-12 get vaccinated.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 16000 (estimated) |
| Ages | 9 Years to 17 Years |
| Sex | All |
| Sponsor | University of Rochester Academic / other |
| Locations | 1 site (Rochester, New York) |
| Trial ID | NCT06380114 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance HPV vaccination rates among adolescents by implementing standing orders that allow healthcare team members to administer the vaccine without a specific physician's order. It addresses the low vaccination rates in the U.S., particularly among 11-12 year-olds, who are the primary target group for HPV vaccination. The study will also explore how organizational readiness for change influences the effectiveness of these standing orders. By evaluating this approach, the study seeks to provide insights into improving vaccination strategies in healthcare settings.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 11-17 who are active patients in participating practices.
Not a fit: Patients who are already part of practices with high baseline HPV vaccination rates or those with very few eligible 11-12 year-olds may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers.
How similar studies have performed: Previous studies have shown that standing orders can effectively improve vaccination rates in other contexts, suggesting potential success for this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * active patient in AHP practice Exclusion Criteria: * patient belonging to a practice with \>80% UTD baseline HPV vaccination rate for ages 13-17 * patient belonging to a practice with \<20 11-12 year-olds eligible for an HPV dose
Where this trial is running
Rochester, New York
- University of Rochester Medical Center (URMC) — Rochester, New York, United States (Recruiting)
Study contacts
- Study coordinator: Robin Bender
- Email: robin_bender@urmc.rochester.edu
- Phone: (585) 274-1499
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.